Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal; Wanzhu Tu; Alfredo E. Farjat; Youssef M.K. Farag; Robert D. Toto; Sanjay Kaul; Robert Lawatscheck; Katja Rohwedder; Luís M. Ruilope; Peter Rossing; Bertram Pitt; Gerasimos Filippatos; Stefan D. Anker; George L. Bakris; Augusto Vallejos; Richard J. MacIsaac; Guntram Schernthaner; Pieter Gillard; Maria Eugênia Fernandes Canziani; Theodora Temelkova‐Kurktschiev; Ellen Burgess; Sheldon W. Tobe; Zhihong Liu; Andrés Ángelo Cadena Bonfanti; Carlos Jaramillo; Martin Prázný; Jorma Strand; Roland E. Schmieder; Christoph Wanner; Pantelis Sarafidis; Juliana C.N. Chan; László Rosivall; Joseph A. Eustace; Giuseppe Remuzzi; Daisuke Koya; Takashi Wada; Magdalena Madero Rovalo; Ron T. Gansevoort; Adriaan Kooy; Trine Finnes; Froilan DeLeon; Janusz Gumprecht; Fernando Teixeira e Costa; Anantharaman Vathsala; Aslam Amod; Sin Gon Kim; Byung‐Wan Lee; Julio Pascual Santos; Bengt-Olov Tengmark; Michel Burnier; Chien‐Te Lee; Sukit Yamwong; Ramazan Sarı; Kieran McCafferty; Borys Mankovsky; Sharon G. Adler; Linda F. Fried; Mark V. Williams; Tran Quang Khanh; Diego Aizenberg; Inés Bartolacci; Diego Besada; Julio Bittar; Mariano Chahin; Alicia Elbert; Elizabeth Gelersztein; Alberto Liberman; Laura Maffei; Federico Pérez Manghi; Hugo Sanabria; Gloria Viñes; Alfredo Wassermann; Walter P. Abhayaratna; Shamasunder Acharya; Elif I. Ekinci; Darren Lee; Peak Mann Mah; Craig Nelson; Alexia Pape; Hugo Stephenson; Michael Suranyi; Elizabeth Vale; Martin Clodi; Christoph Ebenbichler; Evelyn Fließer-Görzer; Ursula Hanusch; Michael Krebs; Karl Lhotta; Bernhard Ludvik; Gert Mayer; Peter Neudorfer

doi:10.7326/m23-1023

Related publications

Dataset

Faculty Opinions recommendation of Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

Giuseppe Remuzzi, Amantia Imeraj

Article2023

Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI

Alessandro Spirito, Dipti Itchhaporia, Samantha Sartori, Edoardo Camenzind, Alaide Chieffo, George Dangas, Søren Galatius, Raban Jeger, David E. Kandzari, Adnan Kastrati, Hyo‐Soo Kim, Takeshi Kimura, Martin B. Leon, Laxmi S. Mehta, Ghada Mikhail, Marie‐Claude Morice, Johny Nicolas, Brunna Pileggi, Patrick W. Serruys, Pieter C. Smits, Philippe Gabríel Steg, Gregg W. Stone, Marco Valgimigli, Birgit Vogel, Clemens von Birgelen, Giora Weisz, William Wijns, Stephan Windecker, Roxana Mehran

EuroIntervention

Article2010

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

Scott D. Solomon, Hajime Uno, Eldrin F. Lewis, Kai‐Uwe Eckardt, Julie Lin, Emmanuel A. Burdmann, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Patrick S. Parfrey, Giuseppe Remuzzi, Ajay Singh, Robert D. Toto, Fannie Huang, Jérôme Rossert, John J.V. McMurray, Marc A. Pfeffer

Article2013

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L. Bakris, Melanie Chin, Heidi Christ‐Schmidt, Angie Goldsberry, Mark T. Houser, Melissa Krauth, Hiddo J.L. Heerspink, John J.V. McMurray, Colin J. Meyer, Hans‐Henrik Parving, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, Janet Wittes, Danielle Wrolstad, Glenn M. Chertow

Article2009

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai-Uwe Eckardt, Jan Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto